The battle of the biolab: Massive Increase in Funds for Biodefense Research and Development (2007)
http://www.thefreelibrary.com/The+battle+of+the+biolabs.-a0163051142
Increased funding for biodefense research and development, the international posture of the Bush administration, and the expansion of Bio Security Level (BSL (language) BSL - A variant of IBM’s PL/S systems language. Versions: BSL1, BSL2. ) 4 labs raise suspicions of an illegal bioweapons program. To clarify, BSL 4 labs are the highest level of containment facilities. At these, research takes place on dangerous and/or exotic agents that have a high risk of causing life-threatening disease, a hazard of aerosol-transmitted infection in the lab, or agents that have an unknown risk of transmission.
America the beautiful’s germ warfare rash. (2007)
http://www.thefreelibrary.com/America+the+beautiful’s+germ+warfare+rash.-a0166051075
Since the September 11, 2001, terrorist attacks, the Bush administration has spent at least $44 billion on biological “defense” without ever making made a true needs assessment. In the early 1990s the Kremlin shut down their huge, Soviet-era germ warfare operation and, while Israel, Iran, and North Korea are known to have biological weapons research facilities and India, China, and Cuba are said to be building high-security labs to study lethal bacteria and viruses, these initial or potential programs are disproportionately behind the massive efforts underway in the United States. In the words of Edward Hammond, director of the Sunshine Project, an Austin, Texas-based group that tracks research involving biological agents: “Our biowarfare research is defending ourselves from ourselves. It’s a dog chasing its tail.”
Germ warfare: agencies scramble to create vaccine market. (2007)
http://www.thefreelibrary.com/Germ+warfare+agencies+scramble+to+create+vaccine+market.-a0165192805
When anthrax was delivered to Capitol Hill and media outlets in envelopes in 2001, the prospect of a widespread biological attack became real to the U.S. government. For Jay Cohen, undersecretary of the Department of Homeland Security’s science and technology division, it’s the possibility of a biological attack that keeps him up at night. While nuclear or radiological weapons require a significant capital and physical investment to develop, “in today’s genomic world, students with microscopes have the potential to develop biological weapons,” he said in an interview with National Defense.
The relative simplicity of deploying a deadly biological agent has prompted the government to seek technological solutions from the private sector. In the aftermath of the anthrax attacks, contractors predicted that a robust biodefense industrial complex would emerge. But so far the market has lagged, experts say. Eleven government agencies now work on biodefense. Several offices within these agencies award contracts and grants to universities and public health organizations to prepare for biological attack.


